The race is on to identify the wonder drug that will treat an increasingly common consequence of obesity: the fatty liver disease known as nonalcoholic steatohepatitis, or NASH.
Pharma Companies Race to Find Wonder Drug for Obesity-Linked Liver Disease
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться